Bayram Özhan
Research Subjects
Bayram Özhan has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Selda Ayça Altıncık
Pamukkale University Faculty of Medicine, Department of Pediatric Endocrinology, Denizli, Turkiye
4 shared publications - Ali Rahmi Bakiler
İzmir ÖZET
2 shared publications Betül Ersoy
Division of Pediatric Endocrinology, Department of Pediatrics, Celal Bayar University Faculty of Medicine Manisa, Turkey
2 shared publications- Emine Kılıç Toprak
Pamukkale Universitesi
2 shared publications Koray Salar
Tepecik Teaching Hospital
2 shared publications- Ozgen Kilic-Erkek
Pamukkale University
2 shared publications
Latest Publications
- Open Access
- 30 December 2025
- Published by Springer Nature in Research Square
The Relationship Between Adipocytokine Levels, Carotid Intima-Media Thickness, and Visceral Fat Distribution in Children Diagnosed with Growth Hormone Deficiency
Background Growth hormone deficiency (GHD) in childhood impairs not only growth but also metabolic and cardiovascular health. Altered adipocytokine profiles, increased visceral fat, and early vascular changes may predispose children with GHD to long-term cardiometabolic risk. We aimed to evaluate adipocytokine profiles, visceral fat distribution, and carotid intima-media thickness (cIMT) in children with GHD, and to investigate their associations with cardiometabolic risk. Methods This prospective case-control study included 34 children with GHD and 34 age- and gender-matched healthy controls. Anthropometric datas, biochemical parameters, and adipocytokine levels (adiponectin, leptin, resistin, apelin) were measured. Visceral fat thickness (VFT), subcutaneous fat thickness (SCFT) and cIMT were assessed by ultrasonography. Group comparisons and correlation analyses were performed using standard statistical tests. Results Children with GHD had significantly lower height, weight SDS, and target height compared with controls. Adiponectin levels were significantly higher in the GHD group [4.04 (SD±3.08) vs. 2.65 (SD±2.05) ng/mL] ( p=0.009 ), whereas leptin, resistin, and apelin did not differ. We observed that cIMT was increased in GHD patients [0.55 (SD±0.05) vs. 0.50 (SD±0.04) mm] ( p<0.001 ), particularly in males. Severe GHD cases had higher leptin and lower IGF-1 SDS compared with moderate GHD, while moderate cases showed higher adiponectin. Correlation analyses revealed positive associations of leptin with BMI, body fat, triglycerides, VLDL, and HOMA-IR, and negative correlations of adiponectin with total cholesterol, triglycerides, LDL, and VLDL. Also, cIMT correlated positively with leptin, insulin, and HOMA-IR. Conclusion Children with GHD demonstrate altered adipocytokine profiles, increased cIMT, and greater visceral fat, suggesting early vascular risk. Early recognition and GH therapy may help prevent long-term cardiometabolic complications.
- 30 December 2025
- Published by Springer Nature in Research Square
Open AccessThe Relationship Between Adipocytokine Levels, Carotid Intima-Media Thickness, and Visceral Fat Distribution in Children Diagnosed with Growth Hormone Deficiency
Background Growth hormone deficiency (GHD) in childhood impairs not only growth but also metabolic and cardiovascular health. Altered adipocytokine profiles, increased visceral fat, and early vascular changes may predispose children with GHD to long-term cardiometabolic risk. We aimed to evaluate adipocytokine profiles, visceral fat distribution, and carotid intima-media thickness (cIMT) in children with GHD, and to investigate their associations with cardiometabolic risk. Methods This prospective case-control study included 34 children with GHD and 34 age- and gender-matched healthy controls. Anthropometric datas, biochemical parameters, and adipocytokine levels (adiponectin, leptin, resistin, apelin) were measured. Visceral fat thickness (VFT), subcutaneous fat thickness (SCFT) and cIMT were assessed by ultrasonography. Group comparisons and correlation analyses were performed using standard statistical tests. Results Children with GHD had significantly lower height, weight SDS, and target height compared with controls. Adiponectin levels were significantly higher in the GHD group [4.04 (SD±3.08) vs. 2.65 (SD±2.05) ng/mL] ( p=0.009 ), whereas leptin, resistin, and apelin did not differ. We observed that cIMT was increased in GHD patients [0.55 (SD±0.05) vs. 0.50 (SD±0.04) mm] ( p<0.001 ), particularly in males. Severe GHD cases had higher leptin and lower IGF-1 SDS compared with moderate GHD, while moderate cases showed higher adiponectin. Correlation analyses revealed positive associations of leptin with BMI, body fat, triglycerides, VLDL, and HOMA-IR, and negative correlations of adiponectin with total cholesterol, triglycerides, LDL, and VLDL. Also, cIMT correlated positively with leptin, insulin, and HOMA-IR. Conclusion Children with GHD demonstrate altered adipocytokine profiles, increased cIMT, and greater visceral fat, suggesting early vascular risk. Early recognition and GH therapy may help prevent long-term cardiometabolic complications.
- Open Access
- 23 December 2024
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (2) , 168-175
Could MOTS-C Levels in Children with Type 1 Diabetes Mellitus Be an İndicator for Early Diabetic Kidney Disease?
Journal of Clinical Research in Pediatric Endocrinology
- 23 December 2024
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (2) , 168-175
Open AccessCould MOTS-C Levels in Children with Type 1 Diabetes Mellitus Be an İndicator for Early Diabetic Kidney Disease?
Journal of Clinical Research in Pediatric Endocrinology
- Open Access
- 30 June 2024
- Published by Aydin Pediatric Society in Trends in Pediatrics
- Vol. 5 (2) , 25-32
The effect of glycemic variability on DNA damage in children with type 1 diabetes mellitus
Objective: The aim of this study was to determine the extent of DNA damage in pediatric patients with type 1 diabetes and the influence of glycemic variability on DNA damage. Method: The study involved 50 patients under the age of 18 with type 1 diabetes and 21 healthy control individuals. The Medtronic iProTM2 Enlite Glucose Sensor® was implanted, and continuous glucose monitoring metrics were calculated, including standard deviation, glucose management indicator, coefficient of variation, time in range, time below range, and time above range. Blood samples were also taken to assess DNA damage and HbA1c levels. Results: The mean age of children with type 1 diabetes was 13.69±2.99 years, and the male-to-female ratio was 30:20. DNA damage was found to be similar in patients with type 1 DM and in a healthy control group. However, among children with type 1 diabetes mellitus, head length, a measure of undamaged DNA, was significantly higher in patients with good glycemic control (HbA1c≤7.5%) than in those with poor glycemic control (HbA1c>7.5%). A positive correlation was observed between DNA damage parameters and % coefficient of variation, a marker of glycemic variability. Conclusion: The correlation between the coefficient of variation and DNA damage demonstrates the critical importance of maintaining consistent glycemic management in diabetes.
- 30 June 2024
- Published by Aydin Pediatric Society in Trends in Pediatrics
- Vol. 5 (2) , 25-32
Open AccessThe effect of glycemic variability on DNA damage in children with type 1 diabetes mellitus
Objective: The aim of this study was to determine the extent of DNA damage in pediatric patients with type 1 diabetes and the influence of glycemic variability on DNA damage. Method: The study involved 50 patients under the age of 18 with type 1 diabetes and 21 healthy control individuals. The Medtronic iProTM2 Enlite Glucose Sensor® was implanted, and continuous glucose monitoring metrics were calculated, including standard deviation, glucose management indicator, coefficient of variation, time in range, time below range, and time above range. Blood samples were also taken to assess DNA damage and HbA1c levels. Results: The mean age of children with type 1 diabetes was 13.69±2.99 years, and the male-to-female ratio was 30:20. DNA damage was found to be similar in patients with type 1 DM and in a healthy control group. However, among children with type 1 diabetes mellitus, head length, a measure of undamaged DNA, was significantly higher in patients with good glycemic control (HbA1c≤7.5%) than in those with poor glycemic control (HbA1c>7.5%). A positive correlation was observed between DNA damage parameters and % coefficient of variation, a marker of glycemic variability. Conclusion: The correlation between the coefficient of variation and DNA damage demonstrates the critical importance of maintaining consistent glycemic management in diabetes.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (12) , e20241177
Effects of valproic acid, levetiracetam, carbamazepine, and oxcarbazepine on thyroid function tests in children
OBJECTIVE: The aim of the study was to evaluate the effects of commonly used medications for epilepsy on thyroid function tests in children.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (12) , e20241177
Open AccessEffects of valproic acid, levetiracetam, carbamazepine, and oxcarbazepine on thyroid function tests in children
OBJECTIVE: The aim of the study was to evaluate the effects of commonly used medications for epilepsy on thyroid function tests in children.
- Open Access
- 30 April 2023
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 16 (2) , 14
The relations of vitamin D receptor gene polymorphisms with risk of obesity, metabolic syndrome, hepatostetosis in Turkish children
Purpose: The aim of study was to determine the relation of vitamin D receptor gene (VDR) polymorphisms of TaqI (rs731236), ApaI (rs7975232), BsmI (rs1544410), FokI (rs10735810) with the risk of obesity, metabolic syndrome and hepatosteatosis in children. Materials and methods: 130 obese and 130 healthy children of age range between 10-16 years included in this study. Anthropometric measurements, biochemical evaluations and abdominal USG of all children were done. Obese and healty children were analyzed for the most common polymorphisms of the VDR gene by restriction fragment length polymorphism’s technique. The diagnosis of metabolic syndrome was made using the International Diabetes Federation criteria. Results: Genotypic distribution of BsmI, FokI, and TaqI polymorphism were found statistically different between obese patients and control group, but genotypic distribution of all studied polymorphisms were not found statistically different in obese patients with metabolic syndrome or hepatosteotosis. Conclusion: BsmI polymorphism (rs1544410) was found to have a significant positive effect on the development of obesity, metabolic syndrome and hepatosteatosis. Children who carry risk factors for childhood obesity could be screened before the development of obesity and associated metabolic complications using the BsmI polymorphism of the VDR gene.
- 30 April 2023
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 16 (2) , 14
Open AccessThe relations of vitamin D receptor gene polymorphisms with risk of obesity, metabolic syndrome, hepatostetosis in Turkish children
Purpose: The aim of study was to determine the relation of vitamin D receptor gene (VDR) polymorphisms of TaqI (rs731236), ApaI (rs7975232), BsmI (rs1544410), FokI (rs10735810) with the risk of obesity, metabolic syndrome and hepatosteatosis in children. Materials and methods: 130 obese and 130 healthy children of age range between 10-16 years included in this study. Anthropometric measurements, biochemical evaluations and abdominal USG of all children were done. Obese and healty children were analyzed for the most common polymorphisms of the VDR gene by restriction fragment length polymorphism’s technique. The diagnosis of metabolic syndrome was made using the International Diabetes Federation criteria. Results: Genotypic distribution of BsmI, FokI, and TaqI polymorphism were found statistically different between obese patients and control group, but genotypic distribution of all studied polymorphisms were not found statistically different in obese patients with metabolic syndrome or hepatosteotosis. Conclusion: BsmI polymorphism (rs1544410) was found to have a significant positive effect on the development of obesity, metabolic syndrome and hepatosteatosis. Children who carry risk factors for childhood obesity could be screened before the development of obesity and associated metabolic complications using the BsmI polymorphism of the VDR gene.
- 12 January 2023
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 36 (5) , 513-516
An exceptionally rare case of Cushing’s syndrome caused by ectopic ACTH syndrome due to olfactory neuroblastoma in childhood
Objectives: Ectopic adrenocorticotropic hormone secretion/syndrome (EAS) is caused by excess secretion of ACTH leading to hypercortisolism by non-pituitary, commonly malignant origins. We present a rare case of esthesioneuroblastoma (ENB) complicated by EAS in the follow-up period. Case presentation: A child presented with nasal obstruction at the age of 10 months. Polypoid mass obstructing the right nasal passage was detected. Magnetic resonance imaging (MRI) showed a lesion limited within the nasal cavity. The lesion was completely removed by nasal endoscopic surgery. The pathologic examination revealed a diagnosis of esthesioneuroblastoma. It was confined to the nasal cavity so chemotherapy/radiotherapy was not administered and began to follow up. At 28 months of age, he presented with rapid weight gain. Laboratory data were consistent with Cushing’s syndrome (CS). High-dose dexamethasone suppression test and imaging studies led us to think of ectopic ACTH syndrome originated from ENB relapse. After partial resection of the tumor, ketoconazole treatment was started along with chemotherapy. Hypercortisolemia was kept under control with ketoconazole treatment as long as the treatment was maintained. Conclusions: Cushing syndrome is a rare endocrine disorder. Adrenal sources of hypercortisolism and ectopic sources of ACTH overproduction should be investigated especially in young children.
- 12 January 2023
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 36 (5) , 513-516
An exceptionally rare case of Cushing’s syndrome caused by ectopic ACTH syndrome due to olfactory neuroblastoma in childhood
Objectives: Ectopic adrenocorticotropic hormone secretion/syndrome (EAS) is caused by excess secretion of ACTH leading to hypercortisolism by non-pituitary, commonly malignant origins. We present a rare case of esthesioneuroblastoma (ENB) complicated by EAS in the follow-up period. Case presentation: A child presented with nasal obstruction at the age of 10 months. Polypoid mass obstructing the right nasal passage was detected. Magnetic resonance imaging (MRI) showed a lesion limited within the nasal cavity. The lesion was completely removed by nasal endoscopic surgery. The pathologic examination revealed a diagnosis of esthesioneuroblastoma. It was confined to the nasal cavity so chemotherapy/radiotherapy was not administered and began to follow up. At 28 months of age, he presented with rapid weight gain. Laboratory data were consistent with Cushing’s syndrome (CS). High-dose dexamethasone suppression test and imaging studies led us to think of ectopic ACTH syndrome originated from ENB relapse. After partial resection of the tumor, ketoconazole treatment was started along with chemotherapy. Hypercortisolemia was kept under control with ketoconazole treatment as long as the treatment was maintained. Conclusions: Cushing syndrome is a rare endocrine disorder. Adrenal sources of hypercortisolism and ectopic sources of ACTH overproduction should be investigated especially in young children.
- Open Access
- 1 December 2022
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 14 (4) , 444-452
Cord Blood Levels of Spexin, Leptin, and Visfatin in Term Infants Born Small, Appropriate, and Large for Gestational Age and Their Association with Newborn Anthropometric Measurements
Children born small for gestational age (SGA) are at risk of future obesity and associated comorbidities. Therefore the identification of risk factors and novel biomarkers which are associated with this risk are needed for early detection and to improve preventive strategies. Spexin (SPX), a novel neuropeptide that is involved in the regulation of obesity and fat metabolism, is a candidate biomarker for predicting obesity and related comorbidities at an early age. The aim of this study was to investigate serum levels of SPX in term infants born small, appropriate, and large for gestational age (LGA) and its association with newborn anthropometric measurements. One hundred and twenty term newborn babies classified as SGA, appropriate for gestational age (AGA), or LGA and their mothers were included. SPX, leptin and visfatin were measured in cord blood and maternal serum by enzyme-linked immunosorbent assay. Fifty-six (46.7%) neonates were girls and 64 (53.3%) were boys. The mean birth weight was 3170.70±663 g, birth length was 48.9±2.79 cm, and head circumference was 34.5±1.67 cm. Birth weights, lengths, and head circumferences of the neonates in the SGA, AGA, and LGA groups were significantly different. Cord blood SPX and leptin levels in the SGA groups were significantly lower than those of both the LGA and AGA groups. Cord blood visfatin levels were significantly lower in the AGA group than the LGA and SGA groups. Maternal SPX levels of SGA babies were significantly lower than those of the mothers in both the LGA and AGA groups, but no significant difference was observed between the SGA and LGA groups. Maternal visfatin levels of the AGA babies were significantly higher than the maternal levels of SGA and LGA groups. There was no difference in terms of maternal leptin levels. Cord blood SPX and leptin levels were positively correlated with birth weight, length and head circumference. Birth weight increased significantly in line with maternal pregestational body mass index. The lowest SPX levels were found in the SGA babies and cord SPX level was significantly correlated with newborn length, weight, and head circumference.
- 1 December 2022
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 14 (4) , 444-452
Open AccessCord Blood Levels of Spexin, Leptin, and Visfatin in Term Infants Born Small, Appropriate, and Large for Gestational Age and Their Association with Newborn Anthropometric Measurements
Children born small for gestational age (SGA) are at risk of future obesity and associated comorbidities. Therefore the identification of risk factors and novel biomarkers which are associated with this risk are needed for early detection and to improve preventive strategies. Spexin (SPX), a novel neuropeptide that is involved in the regulation of obesity and fat metabolism, is a candidate biomarker for predicting obesity and related comorbidities at an early age. The aim of this study was to investigate serum levels of SPX in term infants born small, appropriate, and large for gestational age (LGA) and its association with newborn anthropometric measurements. One hundred and twenty term newborn babies classified as SGA, appropriate for gestational age (AGA), or LGA and their mothers were included. SPX, leptin and visfatin were measured in cord blood and maternal serum by enzyme-linked immunosorbent assay. Fifty-six (46.7%) neonates were girls and 64 (53.3%) were boys. The mean birth weight was 3170.70±663 g, birth length was 48.9±2.79 cm, and head circumference was 34.5±1.67 cm. Birth weights, lengths, and head circumferences of the neonates in the SGA, AGA, and LGA groups were significantly different. Cord blood SPX and leptin levels in the SGA groups were significantly lower than those of both the LGA and AGA groups. Cord blood visfatin levels were significantly lower in the AGA group than the LGA and SGA groups. Maternal SPX levels of SGA babies were significantly lower than those of the mothers in both the LGA and AGA groups, but no significant difference was observed between the SGA and LGA groups. Maternal visfatin levels of the AGA babies were significantly higher than the maternal levels of SGA and LGA groups. There was no difference in terms of maternal leptin levels. Cord blood SPX and leptin levels were positively correlated with birth weight, length and head circumference. Birth weight increased significantly in line with maternal pregestational body mass index. The lowest SPX levels were found in the SGA babies and cord SPX level was significantly correlated with newborn length, weight, and head circumference.
- Open Access
- 26 February 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (1) , 231-237
Does fludrocortisone treatment cause hypomagnesemia in children with primary adrenal insufficiency?
Background/aim: Aldosterone is a mineralocorticoid that secreted from adrenal glands and a known factor to increase magnesium excretion by direct and indirect effects on renal tubular cells. Although the frequency of hypomagnesemia was found to be approximately 5% in adult studies, there is no study in the literature investigating the frequency of hypomagnesemia in children by using fludrocortisone, which has a mineralocorticoid activity. Materials and methods: A multi-center retrospective study was conducted, including children who were under fludrocortisone treatment for primary adrenal insufficiency and applied to participant pediatric endocrinology outpatient clinics. Results: Forty-three patients (58.1% male, 41.9% prepubertal) included in the study, whose median age was 9.18 (0.61-19) years, and the most common diagnosis among the patients was a salt-wasting form of congenital adrenal hyperplasia (67.4%). Mean serum magnesium level was 2.05 (+/- 0.13) mg/dL, and hypomagnesemia was not observed in any of the patients treated with fludrocortisone. None of the patients had increased urinary excretion of magnesium. Conclusion: Unlike the studies performed in adults, we could not find any evidence of magnesium wasting effect of fludrocortisone treatment with normal or even high doses in children and adolescents.
- 26 February 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (1) , 231-237
Open AccessDoes fludrocortisone treatment cause hypomagnesemia in children with primary adrenal insufficiency?
Background/aim: Aldosterone is a mineralocorticoid that secreted from adrenal glands and a known factor to increase magnesium excretion by direct and indirect effects on renal tubular cells. Although the frequency of hypomagnesemia was found to be approximately 5% in adult studies, there is no study in the literature investigating the frequency of hypomagnesemia in children by using fludrocortisone, which has a mineralocorticoid activity. Materials and methods: A multi-center retrospective study was conducted, including children who were under fludrocortisone treatment for primary adrenal insufficiency and applied to participant pediatric endocrinology outpatient clinics. Results: Forty-three patients (58.1% male, 41.9% prepubertal) included in the study, whose median age was 9.18 (0.61-19) years, and the most common diagnosis among the patients was a salt-wasting form of congenital adrenal hyperplasia (67.4%). Mean serum magnesium level was 2.05 (+/- 0.13) mg/dL, and hypomagnesemia was not observed in any of the patients treated with fludrocortisone. None of the patients had increased urinary excretion of magnesium. Conclusion: Unlike the studies performed in adults, we could not find any evidence of magnesium wasting effect of fludrocortisone treatment with normal or even high doses in children and adolescents.
- 15 June 2020
- Published by Aydin Pediatric Society in Trends in Pediatrics
- Vol. 1 (2) , 55-60
Testicular Adrenal Rest Tumors in Patients with Congenital Adrenal Hyperplasia: A Case Series
Objective: Testicular adrenal rest tumors (TARTs) are the main etiology of infertility in congenital adrenal hyperplasia (CAH). The aim of this study is to determine the patients diagnosed with TART and to evaluate the risk factors associated with the development of the disease. Methods: Clinical characteristics of 31 patients with CAH including 19 male, and 12 female patients who were followed up in our clinic were retrospectively reviewed regarding the presence of TART. Differences between clinical and laboratory findings of patients with and without TART were examined. Six male patients with TART were included in the study. Clinical characteristics such as pubertal stage, treatment doses, laboratory findings were evaluated. Changes in size of TARTs were examined with ultrasound follow-ups at six month- intervals. Results: The prevalence of TARTs was 31.5 % (6/19 male). Precocious puberty was higher in patients with TART than without TART. The mean age of the patients was 9.1±2.4 (range: 5.2-12.4) years at the time of diagnosis with TART. Five patients with TART were inadequately controlled. Four patients had a history of precocious puberty. Tumor progression was detected in 4 of 6 patients. In three patients with tumor progression, serum 17-hydroxy progesterone (17-OHP) values increased during follow-up, probably due to non-compliance with treatment. Conclusion: Scrotal ultrasound monitoring should be performed in all male patients with CAH in early childhood irrespective of disease control.
- 15 June 2020
- Published by Aydin Pediatric Society in Trends in Pediatrics
- Vol. 1 (2) , 55-60
Testicular Adrenal Rest Tumors in Patients with Congenital Adrenal Hyperplasia: A Case Series
Objective: Testicular adrenal rest tumors (TARTs) are the main etiology of infertility in congenital adrenal hyperplasia (CAH). The aim of this study is to determine the patients diagnosed with TART and to evaluate the risk factors associated with the development of the disease. Methods: Clinical characteristics of 31 patients with CAH including 19 male, and 12 female patients who were followed up in our clinic were retrospectively reviewed regarding the presence of TART. Differences between clinical and laboratory findings of patients with and without TART were examined. Six male patients with TART were included in the study. Clinical characteristics such as pubertal stage, treatment doses, laboratory findings were evaluated. Changes in size of TARTs were examined with ultrasound follow-ups at six month- intervals. Results: The prevalence of TARTs was 31.5 % (6/19 male). Precocious puberty was higher in patients with TART than without TART. The mean age of the patients was 9.1±2.4 (range: 5.2-12.4) years at the time of diagnosis with TART. Five patients with TART were inadequately controlled. Four patients had a history of precocious puberty. Tumor progression was detected in 4 of 6 patients. In three patients with tumor progression, serum 17-hydroxy progesterone (17-OHP) values increased during follow-up, probably due to non-compliance with treatment. Conclusion: Scrotal ultrasound monitoring should be performed in all male patients with CAH in early childhood irrespective of disease control.
- 1 January 2020
- Vol. 24 (21) , 10999-11005
Acanthosis nigricans: a warning sign of lower urinary tract dysfunction in obese children?
OBJECTIVE: There have been very few studies on the relationship between lower urinary tract dysfunction (LUTD) and obesity-related metabolic disorders in the pediatric age group. This study investigated the relationship between LUTD and metabolic disturbances in obese children. PATIENTS AND METHODS: Four-hundred obese children (body mass index >= 95th percentile) were included in the present study. Anthropometric. clinical, and biochemical parameters were evaluated. The Dysfunctional Voiding and Incontinence Scoring System (DVISS) questionnaire was administered and scores over 8.5 were considered to be reflective of LUTD. Subjects were stratified into two groups based on DVISS symptom scores - obese children with and without LUTD. The homeostasis assessment model was used to evaluate insulin resistance and the International Diabetes Federation criteria to identify metabolic syndrome. RESULTS: Lower urinary tract dysfunction was detected in 19% of the study population. There were no significant differences between the two groups in terms of laboratory results. No statistically significant relationship was found between LUTD and the presence of metabolic syndrome or insulin resistance; however, a significant association was observed between LUTD and acanthosis nigricans. Regression analysis revealed that only the presence of acanthosis nigricans significantly increased the risk of lower urinary tract dysfunction by 1.75-fold (p < 0.05). CONCLUSIONS: The presence of acanthosis nigricans in obese children may suggest the concurrent occurrence of lower urinary tract dysfunction and should be investigated accordingly.
- 1 January 2020
- Vol. 24 (21) , 10999-11005
Acanthosis nigricans: a warning sign of lower urinary tract dysfunction in obese children?
OBJECTIVE: There have been very few studies on the relationship between lower urinary tract dysfunction (LUTD) and obesity-related metabolic disorders in the pediatric age group. This study investigated the relationship between LUTD and metabolic disturbances in obese children. PATIENTS AND METHODS: Four-hundred obese children (body mass index >= 95th percentile) were included in the present study. Anthropometric. clinical, and biochemical parameters were evaluated. The Dysfunctional Voiding and Incontinence Scoring System (DVISS) questionnaire was administered and scores over 8.5 were considered to be reflective of LUTD. Subjects were stratified into two groups based on DVISS symptom scores - obese children with and without LUTD. The homeostasis assessment model was used to evaluate insulin resistance and the International Diabetes Federation criteria to identify metabolic syndrome. RESULTS: Lower urinary tract dysfunction was detected in 19% of the study population. There were no significant differences between the two groups in terms of laboratory results. No statistically significant relationship was found between LUTD and the presence of metabolic syndrome or insulin resistance; however, a significant association was observed between LUTD and acanthosis nigricans. Regression analysis revealed that only the presence of acanthosis nigricans significantly increased the risk of lower urinary tract dysfunction by 1.75-fold (p < 0.05). CONCLUSIONS: The presence of acanthosis nigricans in obese children may suggest the concurrent occurrence of lower urinary tract dysfunction and should be investigated accordingly.